Alivus Life Sciences Limited has informed the Exchange about Schedule of meet
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences Limited has informed the exchanges about an upcoming investor/analyst meeting scheduled for May 23, 2025. The company representatives will meet with Unifi Capital in a one-on-one, in-person format at Chennai. This disclosure is being made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The note also mentions that the schedule and mode of meeting may change due to exigencies. The filing is signed by Rudalf Corriea, Company Secretary & Compliance Officer. Scrip Code is 543322 on BSE and ALIVUS on NSE.
This is a routine regulatory disclosure about a scheduled investor/analyst engagement and does not contain any material business or financial information. Such meetings are standard corporate communication activities and typically have no direct impact on share price, though investor discussions sometimes provide directional cues on management's outlook.